期刊文献+

FISH和IHC检测乳腺癌患者HER2/neu基因影响因素的研究 被引量:3

Research on effecting factor of the detection of HER2/neu gene expression in patients with breast cancer by fluorescence in-situ hybridization and by immunohistochemistry
下载PDF
导出
摘要 目的观察乳腺癌石蜡包埋组织荧光原位杂交(FISH)和免疫组化(IHC)检测乳腺癌患者HER2/neu基因状态,比较不同切片方法及不同结果判读人员的经验区别。方法 55例乳腺癌石蜡包埋组织分组切片和观察判读,观察1组:由技术人员选定区域切片,平行检测HER2/neu基因状态;观察2组:先切片做HE染色,由初级病理医师根据病理图像选定区域后切片,平行检测HER2/neu基因状态,并由初级病理医师分析结果;观察3组,由中、高级病理医师根据病理图像选定区域后重新切片检测,判读分析。结果观察1组和观察2组,IHC(-)和IHC(1+)与FISH检测一致性较好,IHC(2+)和IHC(3+)与FISH检测的相符率分别为33.33%/33.33%,50.00%/100.00%;2组的一致性分别为中等和较好(K1=0.478,K2=0.659);共有10例患者入选观察3组,重新切片后,6例患者结果不同,其中3例为取材误差,3例为判读误差,3例取材误差均出现在观察1组。结论 FISH和IHC检测乳腺癌患者HER2/neu基因状态受到制片、结果判读等多种因素影响,实验室应制定标准化的操作程序,严密的质量控制和质量保证措施,才可得到准确而可靠的结果。 Objective To compare the influence of different sampling methods and observers on the detection of HER2/neu gene expression in paraffin-embedded tissue of breast cancer by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). Methods 55 cases of paraffin embedded tissues of breast cancer were grouped according to section and observation. In Ob- served Group 1, target section regions were selected and parallel observed by technical staff. In Observed-Group 2, the tissue were first sliced and dyed with HE, the regions for section were selected by ordinary pathologists according to the pathological images, the HER2/neu gene was detected meanwhile and then the results were judged by the same ordinary pathologists. In Observed- Group 3, the regions for section were selected according to the pathological images and the tissues were sliced again and judged by professional pathologists. Results In Observed Group 1 and Observed-Group 2, there was fine consistency between IHC( ), IHC (--) and FISH, and the coincidence was 33.33 %/33.33% and 50.00 %/100.00% between IHC(2 + ), IHC(3-7 ) and FISH. The consistency of Observed Group 1 and 2 were moderate and preferable(K1 = 0. 478,K2 = 0. 659). 10 cases were grouped into the Ob served-Group 3, among which, after section again, 6 cases were obtained with different results, including 3 cases of sampling error from Observed Group 1, and 3 cases of error judgment. Conclusion Detection of HER2/neu gene in breast cancer by FISH and IHC was influenced by many factors, such as slice preparation and result interpretation. Standardized operating procedures and measures for quality control and assurance should be developed to obtain accurate and reliable results.
出处 《国际检验医学杂志》 CAS 2012年第3期268-270,共3页 International Journal of Laboratory Medicine
基金 卫生部科研基金课题(WKJ2007-3-001)
关键词 原位杂交 荧光 免疫组织化学 乳腺肿瘤 表皮生长因子 标准化 in-situ hybridization, fluorescence immunohistochemistry breast neoplasms epidemal growth factor standardization
  • 相关文献

参考文献13

  • 1Ross JS, Gray GS. Targeted therapy for cancer: the HER-2/neu and Herceptin story[J]. Clin Leadersh Manag Rev, 2003,17 (6) : 333-340.
  • 2黄俊,邓明凤,郭华雄,陈登峰,王昌富.荧光原位杂交(FISH)技术与免疫组织化学(IHC)技术应用于乳腺癌患者Her2基因检测的评价[J].现代检验医学杂志,2010,25(3):92-94. 被引量:4
  • 3<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 4刘静芸,林婴,杨季云.荧光原位杂交技术对多发性骨髓瘤染色体异常的检测及意义[J].国际检验医学杂志,2009,30(4):349-350. 被引量:4
  • 5向阳,府伟灵.荧光原位杂交检测细胞中hTERC基因扩增在宫颈癌早期诊断中的意义[J].国际检验医学杂志,2009,30(8):733-736. 被引量:2
  • 6Powell WC, Hicks DG,Prescott N, et al. A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determina- tion of the HER2 status in breast cancer:comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory re- producibility[J]. Appl Immunohistochem Mol Morphol, 2007,15 (1) :94-102.
  • 7Roche PC,Surnan VJ,Jebkins RB, et al. Concordance between locat and central laboratory HER2 testing in the breast intergroup trial N9381[J]. J Natl Cancer Inst,2002,94(11):855-857.
  • 8Moeder CB,Gilmane JM, Harigopal M, et al. Quantitative justifi cation of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clini- cal Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue mi croarray based assessment of outcome[J]. J Clin Oncol, 2007,25 (34) :5418 5425.
  • 9Hsu CY. Ho DM. Yang CF,et al. Interobserver reproducibility of HER-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest[J]. Am J Clin Patbol, 2002, 118 (5) :693-698.
  • 10Santinelli A, Baccarini M, Colanzi P, et al. Immunohistochemical evaluation of HER2/neu expression in infiltrating breast cancino ma : a study of reproducibility[J]. Anal Quant Cytol Histol, 2002, 24(1) ,54-62,.

二级参考文献34

共引文献169

同被引文献19

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部